androstenedione has been researched along with Hormone-Dependent Neoplasms in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (21.28) | 18.7374 |
1990's | 28 (59.57) | 18.2507 |
2000's | 6 (12.77) | 29.6817 |
2010's | 3 (6.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Roy, K; Roy, PP | 1 |
Chen, S; Hong, Y; Rashid, R | 1 |
Hartmann, MF; Kamrath, C; Wudy, S | 1 |
Dixon, JM; Miller, WR; Sahmoud, T; Stuart, M | 1 |
Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E | 1 |
Brodie, A; Guo, Z; Macedo, LF; Qiu, Y; Sabnis, GJ; Tilghman, SL | 1 |
Ioannidis, JP; Mauri, D; Pavlidis, N; Polyzos, NP | 1 |
Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE | 1 |
Brodie, AM; Garrett, WM; Hendrickson, JR; Tsai-Morris, CH | 1 |
Geller, J | 1 |
Murray, R; Pitt, P | 1 |
Attili, A; Bajetta, E; Bartoli, C; Buzzoni, R; Ferrari, L; Lepera, P; Martinetti, A; Noberasco, C; Sacchini, V; Zilembo, N | 1 |
Alberola Candel, V; Calabresi, F; Delozier, T; Feuilhade, F; Freue, M; Goss, P; Mauriac, L; Michel, RT; Pérez Carrión, R; Santos, R | 1 |
Brueggemeier, RW | 1 |
Brodie, AM | 1 |
Boccardo, F; Decensi, A; Marroni, P; Padovani, P; Pensa, F; Torrisi, R | 1 |
Brandt, ME; Covey, DF; Puett, D; Zimniski, SJ | 1 |
Maggino, T; Marcadella, CB; Romagnolo, C | 2 |
Detre, S; Dowsett, M; Grimshaw, R; Lee, K; Macaulay, VM; Rowlands, M | 1 |
Coombes, RC; Corbishley, C; Ford, HT; Gazet, JC; Griffin, M; Lowndes, S; Makinde, V; Quilliam, J; Sutcliffe, R | 1 |
Rose, C | 1 |
Buzdar, AU; Roseman, BJ; Singletary, SE | 1 |
Anderson, ED; Anderson, TJ; Cameron, DA; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC; Levack, P | 1 |
Lønning, PE | 1 |
Hida, N; Labrie, F; Poulin, R; Veilleux, R | 1 |
Diep, AT; Haile, RW; Henderson, BE; Ingles, SA; Kolonel, LN; Probst-Hensch, NM; Stanczyk, FZ | 1 |
Dowsett, M | 1 |
Coombes, RC; Dowsett, M; Harper-Wynne, C | 1 |
Harvey, HA; Santen, RJ | 1 |
Adamski, J; Breitling, R; Krazeisen, A; Möller, G | 1 |
Lombardi, P | 1 |
Brodie, AM; Brodie, HJ; Marsh, D | 1 |
Ascoli, M; Lacroix, A; McKenna, TJ; Puett, D | 1 |
Christodoulides, A; Ghilchik, MW; Koistinen, R; Reed, MJ; Seppälä, M; Teale, JD | 1 |
Frei, E; Kantoff, PW; LeBlanc, GA; Ng, SF; Waxman, DJ | 1 |
de Jong, FH; Moerings, EP; Schröder, FH; van Kreuningen, A; van Steenbrugge, GJ; van Weerden, WM | 1 |
Bartsch, G; Graf, AH; Hartmann, H; Klocker, H; Schiller, CD; Schneider, MR | 1 |
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Reed, MJ; Shaikh, NA | 1 |
Distler, W; von Matthiessen, H | 1 |
Banks, PK; Brodie, AM; Coombes, RC; Dowsett, M; Inkster, SE | 1 |
Miller, WR | 1 |
Bressel, M; Kastendieck, H; Klein, H; Voigt, KD | 1 |
Brueggemeier, RW; Li, PK | 1 |
Brandt, ME; Covey, DF; Fendl, K; Garola, R; Puett, D; Zimniski, SJ | 1 |
Feil, PD; Leszczynski, D; Manni, A; Santen, RJ; Santner, SJ; Tilson-Mallet, N; Wright, C | 1 |
Brodie, AM; Coombes, RC; Dowsett, M; Goss, P; Wing, LY | 1 |
17 review(s) available for androstenedione and Hormone-Dependent Neoplasms
Article | Year |
---|---|
[The alternative androgen synthesis pathway in humans].
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenal Hyperplasia, Congenital; Androgens; Androstenedione; Animals; Child; Child, Preschool; Dehydroepiandrosterone; Dihydrotestosterone; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Pregnancy; Prostatic Neoplasms; Sex Differentiation; Steroid 21-Hydroxylase; Testis; Testosterone | 2013 |
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles | 2005 |
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Topics: Adult; Aged; Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2006 |
Aromatase inhibitors--mechanisms of steroidal inhibitors.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Drug Design; Female; Humans; Neoplasms, Hormone-Dependent; Steroids; Structure-Activity Relationship | 1994 |
Aromatase, its inhibitors and their use in breast cancer treatment.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Half-Life; Humans; Neoplasms, Hormone-Dependent; Pargyline | 1993 |
The control and biological importance of intratumoural aromatase in breast cancer.
Topics: Adenocarcinoma; Androgens; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Male; Mice; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nitriles; Triazoles; Tumor Cells, Cultured | 1996 |
Proper sequence of endocrine therapies in advanced breast cancer.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Premenopause | 1996 |
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles | 1997 |
Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer.
Topics: Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Postmenopause | 1998 |
Drug and hormone interactions of aromatase inhibitors.
Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Estrogens; Fadrozole; Female; Humans; Letrozole; Male; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Sensitivity and Specificity; Tamoxifen; Triazoles | 1999 |
Aromatase inhibitors and their use in the sequential setting.
Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles | 1999 |
Use of aromatase inhibitors in breast carcinoma.
Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Tamoxifen; Triazoles | 1999 |
Exemestane, a new steroidal aromatase inhibitor of clinical relevance.
Topics: Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Receptor Modulators; Estrogens; Female; Humans; Neoplasms, Hormone-Dependent | 2002 |
Aromatase inhibitors and hormone-dependent cancers.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Humans; Neoplasms, Hormone-Dependent | 1990 |
Aromatase inhibitors in the treatment of advanced breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Imidazoles; Neoplasms, Hormone-Dependent; Nitriles | 1989 |
Aromatase and aromatase inhibitors: from enzymology to selective chemotherapy.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Neoplasms, Hormone-Dependent; Pargyline; Rats | 1988 |
Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Topics: 17-Hydroxysteroid Dehydrogenases; Adrenalectomy; Aminoglutethimide; Androstenedione; Animals; Aromatase; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Hydrocortisone; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Sulfatases; Testolactone | 1986 |
5 trial(s) available for androstenedione and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Radioimmunoassay; Receptors, Estrogen; Triazoles | 2002 |
Formestane: effective therapy in postmenopausal women with advanced breast cancer.
Topics: 17-Hydroxycorticosteroids; Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Estradiol; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen | 1994 |
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1994 |
Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretion.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Androgen Antagonists; Androgens; Androstenedione; Antineoplastic Agents; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Triptorelin Pamoate | 1994 |
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Goserelin; Humans; Hydrocortisone; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Prednisone; Preoperative Care; Tamoxifen; Treatment Outcome; Vincristine | 1997 |
25 other study(ies) available for androstenedione and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Catalytic Domain; Chemical Phenomena; Estrogens; Female; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Neoplasms, Hormone-Dependent; Quantitative Structure-Activity Relationship | 2010 |
Binding features of steroidal and nonsteroidal inhibitors.
Topics: Amino Acids; Androgens; Androstadienes; Androstenedione; Aromatase; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Catalytic Domain; Estrogens; Estrone; Female; Humans; Letrozole; Mutagenesis, Site-Directed; NADPH-Ferrihemoprotein Reductase; Neoplasms, Hormone-Dependent; Nitriles; Protein Conformation; Structure-Activity Relationship; Triazoles | 2011 |
Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.
Topics: Androgen Receptor Antagonists; Androgens; Androstenedione; Aromatase; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dihydrotestosterone; Estradiol; Estrogen Receptor alpha; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Proto-Oncogene Proteins c-bcl-2; Receptors, Androgen; RNA, Small Interfering; Transfection; Triazoles | 2006 |
Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Hormones; Humans; Hydrocortisone; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Prolactin | 1984 |
Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstatrienes; Androstenedione; Animals; Aromatase Inhibitors; Castration; Estrogens; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Hormone-Dependent; Ovary; Oxidoreductases; Rats | 1982 |
Basis for hormonal management of advanced prostate cancer.
Topics: Androstenedione; Animals; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Biosynthesis; Rats; Testosterone | 1993 |
Treatment of advanced breast cancer with formestane.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Remission Induction; Survival Analysis | 1994 |
Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogens; Estrus; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Pargyline; Rats; Rats, Sprague-Dawley | 1993 |
The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias. b). Renin.
Topics: Adipose Tissue; Androstenedione; Blood Pressure; Breast Neoplasms; Dehydroepiandrosterone; Endometrial Neoplasms; Female; Humans; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Renin; Sex Hormone-Binding Globulin; Testosterone | 1993 |
The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias. a). Insulin.
Topics: Androstenedione; Blood Glucose; Body Weight; Breast Neoplasms; Dehydroepiandrosterone; Endometrial Neoplasms; Female; Glucose Tolerance Test; Humans; Insulin; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Goserelin; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasms, Hormone-Dependent; Receptors, Estrogen | 1996 |
Differential androgen sensitivity is associated with clonal heterogeneity in steroid metabolism, ornithine decarboxylase regulation and IL-1alpha action in mouse mammary tumor cells.
Topics: Androgens; Androstenediol; Androstenedione; Animals; Binding Sites; Cell Division; Clone Cells; Dehydroepiandrosterone; Dihydrotestosterone; Interleukin-1; Male; Mammary Neoplasms, Experimental; Mice; Mitogens; Neoplasms, Hormone-Dependent; Ornithine Decarboxylase; Steroids; Testosterone; Tumor Cells, Cultured | 1999 |
Aromatase and breast cancer susceptibility.
Topics: Aged; Androstenedione; Aromatase; Breast Neoplasms; Disease Susceptibility; Estrogens; Estrone; Ethnicity; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Polymorphism, Genetic; Postmenopause; Risk Factors | 1999 |
Human 17beta-hydroxysteroid dehydrogenase type 5 is inhibited by dietary flavonoids.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Androstane-3,17-diol; Androstenedione; Androsterone; Anticarcinogenic Agents; Binding Sites; Diet; Enzyme Inhibitors; Estrogens, Non-Steroidal; Flavonoids; Humans; Hydroxylation; Hydroxyprostaglandin Dehydrogenases; Isoflavones; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Phytoestrogens; Plant Preparations; Plants, Edible; Recombinant Fusion Proteins; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen; Testosterone | 2002 |
Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Oxidoreductases; Progesterone; Prolactin; Rats; Testosterone | 1979 |
Steroidogenesis in HCG-responsive Leydig cell tumor variants.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Animals; Chorionic Gonadotropin; Dihydrotestosterone; Hydroxyprogesterones; Leydig Cell Tumor; Male; Mice; Neoplasms, Hormone-Dependent; Pregnenolone; Progesterone; Steroid 17-alpha-Hydroxylase; Steroids; Testosterone | 1979 |
The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer.
Topics: Aged; Androstenedione; Breast Neoplasms; Carrier Proteins; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen | 1992 |
Hormonal perturbations in patients with testicular cancer treated with cisplatin.
Topics: Adult; Androstenedione; Chorionic Gonadotropin; Cisplatin; Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Neoplasms, Hormone-Dependent; Testicular Neoplasms; Testosterone | 1992 |
Pharmacia Award 1990. The biological significance of low testosterone levels and of adrenal androgens in transplantable prostate cancer lines.
Topics: Adenocarcinoma; Androstenedione; Animals; Awards and Prizes; Castration; Dehydroepiandrosterone; Europe; Humans; Male; Mice; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Societies, Medical; Testosterone; Urology | 1991 |
Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma.
Topics: Adenocarcinoma; Androstenedione; Animals; Castration; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Male; Neoplasms, Hormone-Dependent; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1991 |
Analysis by DNA polymerase alpha activity of human breast tumour proliferation and the effect of endocrine therapy.
Topics: Androstenedione; Antineoplastic Agents; Biopsy; Breast Neoplasms; DNA Polymerase II; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen | 1990 |
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen | 1990 |
Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer.
Topics: 17-Hydroxysteroid Dehydrogenases; Adrenal Glands; Androgens; Androstenediols; Androstenedione; Arylsulfatases; Cholestenone 5 alpha-Reductase; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Humans; Lymphatic Metastasis; Male; Neoplasms, Hormone-Dependent; Oxidoreductases; Prostate; Prostatic Neoplasms; Steryl-Sulfatase; Testosterone | 1988 |
Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Estrogens; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Rats, Inbred Strains | 1988 |
Aromatase inhibitors and the treatment of breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Kinetics; Luteinizing Hormone; Macaca mulatta; Mammary Neoplasms, Experimental; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Rats; Tamoxifen | 1986 |